US and China agree to a tactical trade truce, suspending port fees and reducing some tariffs, but key issues remain unresolved.
Trump announces resumption of nuclear testing, raising concerns about arms race and escalation
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
US and China agree to a tactical trade truce, suspending port fees and reducing some tariffs, but key issues remain unresolved.
Trump announces resumption of nuclear testing, raising concerns about arms race and escalation
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.